Breaking News, Promotions & Moves

Glenmark Appoints New Innovation Company CEO

Dr. Alessandro Riva will lead the new company, which will be a wholly-owned subsidiary of Glenmark and based in Paramus, NJ

Glenmark Pharmaceuticals has announced that Alessandro Riva, MD, will join its new innovation company as chief executive officer.  Alessandro is currently executive vice president, Oncology Therapeutics and Cell Therapy for Gilead Sciences. The appointment is effective April 2, 2019. Glenmark Pharmaceuticals announced on February 14, 2019, the in-principle approval from its Board of Directors to spin off the innovation business into a new company headquartered in the US. The new company wi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters